Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid type A-rho receptor (GABAA-ρ) is a member of the GABA_A receptor family, mediating inhibitory neurotransmission in the central nervous system. GABAA-ρ receptors are distinguished by their unique ρ subunits and distinct pharmacological properties compared to classical GABA_A receptors. They form functional receptors through the oligomerization of five ρ subunits, creating a chloride ion-conducting pore. These receptors are primarily found in retinal neurons, where they contribute to visual signal processing, but are also present at lower levels in other brain regions. They are activated by GABA and exhibit distinct pharmacology, being insensitive to benzodiazepines and barbiturates but selectively modulated by certain neuroactive steroids.
Chloride ion influx leading to neuronal hyperpolarization
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A-rho receptor (None).